Analyst firms · Citigroup · ARVN
Citigroup ARVN price target and rating history
Arvinas Inc. (ARVN) · Health Care
Citigroup rates Arvinas Inc. (ARVN) Buy with a $15 price target, as of its latest action on Jan 6, 2026. It has published 3 rating actions on ARVN since July 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $15
- Median target, all firms
- Too few
- Actions on ARVN
- 3
Citigroup price target on ARVN
Every Citigroup rating on ARVN
- Jan 6, 2026
- Feb 14, 2024
- Jul 23, 2021
How other firms rate ARVN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Equal Weight | Aug 4, 2026 | |
| Citigroup | Buy | $15 | Jan 6, 2026 |
Questions about Citigroup and ARVN
- What is Citigroup's price target for ARVN?
- Citigroup's latest stated price target for Arvinas Inc. (ARVN) is $15, from its action on Jan 6, 2026.
- What is Citigroup's rating on ARVN?
- Citigroup rates ARVN Buy, a bullish rating, as of Jan 6, 2026.
- When did Citigroup last change its view on ARVN?
- On Jan 6, 2026, Citigroup upgrades to Buy from Neutral, price target $15.
More ARVN rating histories
All Citigroup ratingsARVN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.